Week 8 Final Exam: NR546 / NR-546
(Latest Update )
Advanced Pharmacology
Psychopharmacology for the
Psychiatric-Mental Health Nurse
Practitioner | Review Questions and
Answers | 100% Correct | Grade A -
Chamberlain
Question:
AD meds: Lifespan Considerations
Answer:
Cholinesterase inhibitors are not recommended in pregnancy and lactation
Question:
AD: Treating Psychiatric and Behavioral Symptoms
Answer:
first-line pharmacologic treatment of aggression and agitation in dementia is
SSRI/SNRI therapy.
,-often treated with antipsychotic medication
binding at the receptor site.
• not FDA approved for dementia treatment due to risks for mortality and
cardiovascular side effects
Question:
If an AD medication is discontinued:
Answer:
the medication may not be as effective if restarted
Question:
Current gold standard of treatment for cognitive symptoms includes
Answer:
pharmacologic management with a cholinesterase inhibitor (ChEIs) and an
N-methyl-Daspartate (NMDA) receptor antagonist.
Question:
Four major causes of Dementia
Answer:
-Alzheimer Disease (AD)
-vascular dementia
-Lewy body dementias (LBD)
, -frontotemporal dementia (FTD)
Question:
Hallmarks of ad seen in the brain at autopsy are
Answer:
(1) amyloid-beta (Aβ), aggregated into plaques
(2) neurofibrillary tangles composed of hyperphosphorylated tau protein
(3) substantial neuronal cell loss
Question:
Differential diagnosis, clinical presentation: Vascular dementia
Answer:
-Impaired abstraction, mental flexibility, processing speed, and working
memory
-Verbal memory is better preserved
-Slower cognitive decline
-Dementia occurs within several months of a stroke
(Latest Update )
Advanced Pharmacology
Psychopharmacology for the
Psychiatric-Mental Health Nurse
Practitioner | Review Questions and
Answers | 100% Correct | Grade A -
Chamberlain
Question:
AD meds: Lifespan Considerations
Answer:
Cholinesterase inhibitors are not recommended in pregnancy and lactation
Question:
AD: Treating Psychiatric and Behavioral Symptoms
Answer:
first-line pharmacologic treatment of aggression and agitation in dementia is
SSRI/SNRI therapy.
,-often treated with antipsychotic medication
binding at the receptor site.
• not FDA approved for dementia treatment due to risks for mortality and
cardiovascular side effects
Question:
If an AD medication is discontinued:
Answer:
the medication may not be as effective if restarted
Question:
Current gold standard of treatment for cognitive symptoms includes
Answer:
pharmacologic management with a cholinesterase inhibitor (ChEIs) and an
N-methyl-Daspartate (NMDA) receptor antagonist.
Question:
Four major causes of Dementia
Answer:
-Alzheimer Disease (AD)
-vascular dementia
-Lewy body dementias (LBD)
, -frontotemporal dementia (FTD)
Question:
Hallmarks of ad seen in the brain at autopsy are
Answer:
(1) amyloid-beta (Aβ), aggregated into plaques
(2) neurofibrillary tangles composed of hyperphosphorylated tau protein
(3) substantial neuronal cell loss
Question:
Differential diagnosis, clinical presentation: Vascular dementia
Answer:
-Impaired abstraction, mental flexibility, processing speed, and working
memory
-Verbal memory is better preserved
-Slower cognitive decline
-Dementia occurs within several months of a stroke
